Biondvax Pharmaceuticals Overview

Biondvax Pharmaceuticals Other Income Expense Net

Other Income/Expense Net for BVXV.

Quarterly Other Income/Expense

-$1.17M

↑ 43.65% YoY

As of Jun 30, 2023

Annual Other Income/Expense (TTM)

$4.58M

↑ 219.57% YoY

Trailing 12 months ending Jun 30, 2023

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin